Declared Dividend • May 21
Final dividend of HK$0.024 announced Shareholders will receive a dividend of HK$0.024. Ex-date: 2nd June 2026 Payment date: 26th June 2026 Dividend yield will be 1.3%, which is lower than the industry average of 1.8%. Payout Ratios Payout ratio: 10%. Cash payout ratio: 21%. Duyuru • May 20
Time Interconnect Technology Limited has completed a Follow-on Equity Offering in the amount of HKD 2.900016 billion. Time Interconnect Technology Limited has completed a Follow-on Equity Offering in the amount of HKD 2.900016 billion.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 138,096,000
Price\Range: HKD 21
Transaction Features: Subsequent Direct Listing Duyuru • May 13
Time Interconnect Technology Limited has filed a Follow-on Equity Offering in the amount of HKD 2.900016 billion. Time Interconnect Technology Limited has filed a Follow-on Equity Offering in the amount of HKD 2.900016 billion.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 138,096,000
Price\Range: HKD 21
Transaction Features: Subsequent Direct Listing Duyuru • Mar 28
Time Interconnect Technology Limited, Annual General Meeting, May 29, 2026 Time Interconnect Technology Limited, Annual General Meeting, May 29, 2026. Duyuru • Mar 16
Time Interconnect Technology Limited to Report Fiscal Year 2025 Final Results on Mar 27, 2026 Time Interconnect Technology Limited announced that they will report fiscal year 2025 final results on Mar 27, 2026 Duyuru • Feb 21
Time Interconnect Technology Limited has completed a Follow-on Equity Offering in the amount of HKD 1.64376 billion. Time Interconnect Technology Limited has completed a Follow-on Equity Offering in the amount of HKD 1.64376 billion.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 108,000,000
Price\Range: HKD 15.22
Transaction Features: Subsequent Direct Listing Duyuru • Feb 10
Time Interconnect Technology Limited has filed a Follow-on Equity Offering in the amount of HKD 1.64376 billion. Time Interconnect Technology Limited has filed a Follow-on Equity Offering in the amount of HKD 1.64376 billion.
Security Name: Ordianry Share
Security Type: Common Stock
Securities Offered: 108,000,000
Price\Range: HKD 15.22
Transaction Features: Subsequent Direct Listing Duyuru • Jan 30
Time Interconnect Technology Limited Announces Board Appointments, Effective February 1, 2026 Time Interconnect Technology Limited announced the appointment of Mr. Chaung Kwai Wing and Mr. Hung Wai Lai William as executive Directors and Dr. Wu Che Yuen Justin as an independent non-executive Director with effect from February 1, 2026. Mr. Chaung, aged 62, has over 38 years of experience in the electronics and cable industry, taking senior positions in sales and marketing and general management. Mr. Chaung joined the Company and its subsidiaries in 2020 and is currently the Chief Operating Officer of the Group and acts as director for several subsidiaries of the Group. Mr. Chaung first joined Linkz Industries Limited in 1996 and was transferred to LTK International Limited following the disposal of Linkz’s electronic cables business in 2007. He re-joined the Group in 2020. Mr. Chaung holds a Master of Business Administration degree and a Bachelor of Science degree from The Chinese University of Hong Kong. Mr. Hung, aged 30, joined the Group in July 2024 and is the Executive Vice President – MedTech of the Group. Mr. Hung is responsible for identifying and evaluating potential overseas investment opportunities to drive the Group’s medical device business, enhancing the research and development and production capabilities of the Group in this sector. Mr. Hung began his career in 2019 as Management Trainee at Lee Kum Kee International Holdings Limited and subsequently developed his expertise in account management, marketing, and business development. Mr. Hung obtained a Bachelor of Science degree from Queen Mary University of London. Mr. Hung has been a fellow member of the Institute of Financial Accountants (UK) since December 2020. Dr. Wu, aged 56, is the Associate Dean (Health Systems) of Faculty of Medicine, CUHK. He is responsible for developing a collaborative ecosystem of private healthcare, medical tech industry in Greater Bay Area and beyond. Dr. Wu is an international leader of digestive diseases. He is currently the President of Asian Pacific Digestive Week Federation, and the Past President of Asian Pacific Association of Gastroenterology and Hong Kong Society of Gastroenterology. He is an eminent medical educator honoured with 8 education awards for his dedication to nurturing future-ready doctors. He founded Asia’s first “Global Physician-Leadership Stream” (GPS) in CUHK, which has been the top undergraduate programme in Hong Kong for over 10 years. Dr. Wu is also the founding director of Hong Kong Institute of Integrative Medicine in CUHK, pioneering the cooperation between Western and Chinese medicine in the healthcare system. He steered the development of the world’s first English Massive Open Online Course (MOOC) on Chinese medicine in collaboration with Coursera. He is serving as board member and chairman of Clinical Governance Committee, a member of the Audit and Risk Committee and a member of the Finance Committee of The Chinese Medicine Hospital of Hong Kong. Dr. Wu is serving as advisor and investor of biomedical technology companies. He is serving as an independent non-executive director in Aptorum Ltd, a Nasdaq-listed biomedical technology company. He is a vice-chairman of Medical Engineering & Innovation Council of Hong Kong Federation of Industries. He also actively contributes to community services, education, and health system development of Greater Bay Area. He is serving in the board of Shaw Prize Foundation, and is a member of Consultative Committee on Guangdong- Hong Kong Co-operation (Guangzhou Nansha). Dr. Wu obtained a Doctor of Medicine degree, a Master of Business Administration degree and a Bachelor in Medicine and Bachelor of surgery degree from CUHK. Dr. Wu is also a fellow of the Hong Kong Academy of Medicine in the specialty of Gastroenterology & Hepatology. Duyuru • Jan 16
Time Interconnect Technology Limited Provides Earnings Guidance for the Year Ended 31 December 2025 Time Interconnect Technology Limited provided earnings Guidance for the year ended 31 December 2025. the net profit of the Group for the Current Year is expected to record an increase in the approximate range of 60% to 70% as compared to the net profit of the Group for the year ended 31 December 2024 (the "Previous Year") as disclosed in its 2024 annual report. The Group considers that such increase was primarily due to (i) the increase in the Group's revenue as driven by the increase in sales orders from data centre in cable assembly sector and server sector; and (ii) the increase in share results of associates, net during the Current Year. Duyuru • Dec 05
Time Interconnect Technology Limited (SEHK:1729) completed the acquisition of Dejinchang Investment Limited for approximately HKD 600 million. Time Interconnect Technology Limited (SEHK:1729) entered into a share purchase agreement to acquire Dejinchang Investment Limited for approximately HKD 650 million on August 28, 2025. The consideration of HKD 460 million subject to the terms and conditions of the share purchase agreement. The consideration for the Sale Shares shall be settled as to HKD 130 million by cash and as to HKD 330 million by the allotment and issuance of the Consideration Shares by the Company to the Vendor under General Mandate. In addition, pursuant to the share purchase agreement, the Company shall procure the Target Group to repay the Shareholder’s Debt in an amount not exceeding HKD 189.87 million. It is expected that the cash portion of the consideration for Sale Shares and repayment of Shareholders’ Debt will be financed by internal resources of the Group.
As of June 30, 2025, Dejinchang Investment Limited reported total common equity of HKD 179.71 million.
The transaction is subject to the Company obtaining the clearance from the Stock Exchange and obtaining the Board and Shareholders’ approval as required under the Listing Rules; the Listing Committee of the Stock Exchange having granted approval for the listing of and permission to deal in the Consideration Shares; The merger control filings required by the competent Authorities have been completed, and the approvals, consents, confirmations of non-objection or exemptions from such Authorities having been obtained.
Completion shall take place on the ten business days of the date on which the last conditions precedent in the share purchase agreement is satisfied or waived, or such other day as may be agreed in writing between the Company and the Vendor. As of August 28, 2025, none of the conditions precedent has been fulfilled.
Time Interconnect Technology Limited (SEHK:1729) completed the acquisition of Dejinchang Investment Limited for approximately HKD 600 million on December 3, 2025. Pursuant to the S&P Agreement, part of the Consideration will be settled by the allotment and issuance of the Consideration Shares credited as fully paid by the Company to the Vendor within 20 business days after the Completion Date. The issue price of the Consideration Shares shall be calculated based on the average closing price per Share as quoted on the Stock Exchange over the 30 consecutive trading days immediately prior to the Completion Date. Accordingly, an aggregate of 21.73 million Consideration Shares will be allotted and issued to the Vendor under the General Mandate pursuant to the S&P Agreement. Duyuru • Aug 15
Time Interconnect Technology Limited to Report First Half, 2025 Results on Aug 28, 2025 Time Interconnect Technology Limited announced that they will report first half, 2025 results on Aug 28, 2025 Duyuru • May 23
Time Interconnect Technology Limited Approves Final Dividend for the Year Ended 31 December 2024 Time Interconnect Technology Limited at its AGM held on May 23, 2025, approved to declare a final dividend of HKD 0.13 per share for the year ended 31 December 2024. Duyuru • Apr 11
Time Interconnect Technology Limited Announces Board and Committee Changes, Effective 11 April 2025 The board of directors of Time Interconnect Technology Limited announced that Ms. Chan Kit Fun Fanny has been appointed as an independent non-executive Director; the chairman of the nomination committee of the Company; and a member of each of the audit committee and the remuneration committee of the Company with effect from 11 April 2025. The biographical details of Ms. Chan are set out below: Ms. Chan, aged 65, has over 30 years of experience in the banking and manufacturing industries. Her experience includes corporate and commercial banking, client coverage, strategic transformation, operations management, internal control and compliance, sales and marketing, new business set up and production management. She currently serves as a consultant to the chairman of KBL Group International Ltd., a company specialising in apparel marketing and manufacturing, with major markets in the United States and a production network across China and Asia. Ms. Chan has also been an independent non-executive director of Win Hanverky Holdings Limited, a company listed on the Stock Exchange (stock code: 3322), since July 2022. Prior to that, Ms. Chan worked for China CITIC Bank International and Standard Chartered Bank in their respective wholesale banking divisions. She was also a senior executive in the subsidiaries of Boto International Holdings Ltd. (currently known as Imagi International Holdings Limited, a company listed on Stock Exchange (stock code: 0585)) from 1994 to 2004 during which she led its marketing of consumer products to global markets and supervised its manufacturing of certain product lines. Ms. Chan obtained her Master of Business Administration degree from The City University London and a Bachelor of Arts degree from The University of Hong Kong. CHANGE OF COMPOSITION OF BOARD COMMITTEE: Following the appointment of Ms. Chan, with effect from 11 April 2025, Mr. Luk Wai Shing has ceased to be the chairman of the Nomination Committee, but will remain as a member of the Nomination Committee. Ms. Chan has been appointed as the chairman of the Nomination Committee and also a member of the Audit Committee and the Remuneration Committee. Duyuru • Mar 30
Time Interconnect Technology Limited, Annual General Meeting, May 23, 2025 Time Interconnect Technology Limited, Annual General Meeting, May 23, 2025. Duyuru • Mar 17
Time Interconnect Technology Limited to Report Fiscal Year 2024 Results on Mar 28, 2025 Time Interconnect Technology Limited announced that they will report fiscal year 2024 results on Mar 28, 2025 Duyuru • Mar 07
Time Interconnect Technology Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 December 2024 Time Interconnect Technology Limited provides unaudited consolidated earnings guidance for the year ended 31 December 2024. For the period, the company expects the net profit of the Group for the Current Year is expected to record an increase in the approximate range of 50% to 65% as compared to the net profit of the Group for the nine months ended 31 December 2023 as disclosed in its 2023 annual report. The Group considers that such increase was primarily due to (a) the longer period covered by the Current Year as compared to the nine months recorded during the Previous Financial Period following the change in the financial year end date; and (b) the increase in revenue generated from medical equipment and data centre in cable assembly sector, and specialty cable in digital cable sector, with all three market segments having better profit margins during the Current Year. 
